Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Gastroprotective effects" refers to the ability of compounds, drugs, or interventions to protect the gastric mucosa from damage due to a variety of insults, such as ethanol, NSAIDs, or stress. This is not a specific molecular target, receptor, enzyme, or protein, but rather a descriptor of a pharmacological activity that may involve multiple distinct pathways—such as suppression of gastric acid secretion, enhancement of mucus or bicarbonate secretion, antioxidant activity, inhibition of inflammation, activation of the Nrf2/HO-1 pathway, modulation of prostaglandins, nitric oxide signaling, or prevention of apoptosis. Various substances—including proton pump inhibitors (e.g., omeprazole), prostaglandin analogues, antioxidants (e.g., sinapic acid), and natural product derivatives—possess gastroprotective effects mediated by diverse and often simultaneous mechanisms[1][2][3][4]. In summary, "gastroprotective effects" is a pharmacological outcome, not a druggable molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastroprotective effects.